← 返回

免疫细胞来源的外泌体用于癌症治疗

英文原题:Immune-Cell-Derived Exosomes for Cancer Therapy.

查看英文原题

Immune-Cell-Derived Exosomes for Cancer Therapy.

PubMed 2022/07/25(内容时间) Mol Pharm Q1 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

外泌体是细胞在正常或病理条件下分泌的一类用于细胞间通讯的细胞外囊泡。免疫细胞来源的外泌体具有免疫调节特性和潜在的治疗特性,在癌症治疗中发挥重要作用。它们表面表达多种抗原,可用于抗原呈递、免疫激活和代谢调节,从而杀伤癌细胞。此外,免疫细胞来源的外泌体由于其优异的生物相容性、低免疫原性和高负载能力,作为有效抗肿瘤治疗中的药物递送平台受到了广泛关注。在本综述中,全面概述了免疫细胞来源外泌体的生物学和治疗特征。系统总结了免疫细胞(包括巨噬细胞、树突状细胞、T细胞、B细胞和NK 细胞)分泌的外泌体的抗肿瘤机制。此外,讨论了免疫细胞来源外泌体作为纳米载体递送抗肿瘤药物(化疗药物、基因、蛋白质等)的应用。更重要的是,指出了免疫细胞来源外泌体面临的现有挑战,并讨论了其抗肿瘤潜力。

展开英文摘要原文

Exosomes are a type of extracellular vesicles secreted by cells in normal or pathological conditions for cell-cell communication. With immunomodulatory characteristics and potential therapeutic properties, immune-cell-derived exosomes play an important role in cancer therapy. They express various antigens on their surface, which can be employed for antigen presentation, immunological activation, and metabolic regulation, leading to the killing of cancerous cells.

In addition, immune-cell-derived exosomes have received extensive attention as a drug delivery platform in effective antitumor therapy due to their excellent biocompatibility, low immunogenicity, and high loading capacity. In this review, the biological and therapeutic characteristics of immune-cell-derived exosomes are comprehensively outlined. The antitumor mechanism of exosomes secreted by immune cells, including macrophages, dendritic cells, T cells, B cells, and natural killer cells, are systematically summarized.

Moreover, the applications of immune-cell-derived exosomes as nanocarriers to transport antitumor agents (chemotherapeutic drugs, genes, proteins, etc. ) are discussed. More importantly, the existing challenges of immune-cell-derived exosomes are pointed out, and their antitumor potentials are also discussed.

论文信息

作者
Zhao Y、Liu T、Zhou M
单位
School of Pharmacy, Nantong University, Nantong 226019, China.China
文献类型
综述 · 非美国政府资助研究
期刊
Molecular pharmaceutics2022 Sep 5
原文标识
PubMed 35876318 · DOI 10.1021/acs.molpharmaceut.2c00407